Stay updated on 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.

Latest updates to the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision tag was updated from v3.4.0 to v3.4.1. This appears to be a minor version update that does not alter study content or user-facing features.SummaryDifference0.1%

- Check44 days agoChange DetectedShow glossary option added; metadata labels updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and a new revision tag v3.4.0 replacing v3.3.4.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page shows a new revision label (v3.3.4) replacing the previous v3.3.3. This appears to be a minor backend/content update with no effect on study details or user interactions.SummaryDifference0.1%

- Check66 days agoChange DetectedSponsor information updated to Hamad Medical Corporation. Recruitment/status metadata added (Last known status was 2023-12; Verified).SummaryDifference0.4%

Stay in the know with updates to 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.